Ex vivo photothermal treatment-induced immunogenic cell death for anticancer vaccine development
International Immunopharmacology · 2024
DOI: 10.1016/j.intimp.2023.111450 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2024. Verfasst von Su Hyun Yu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Microbiology and Immunology, College of Pharmacy, Inje University, 197 Injero, Gimhae, Gyeongnam 50834, Republic of Korea. Hauptthemen laut MEDLINE: Neoplasms, Vaccines, Cancer Vaccines. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: Ministry of Science, ICT and Future Planning, National Research Foundation of Korea.
Abstract (Originalsprache)
Photothermal therapy is an anti-cancer strategy that induce cell death by converting light energy into heat energy. During photothermal therapy, cancer cells were treated with photothermal agents, such as indocyanine green, and irradiated with a laser. Heat stress in cancer cells results in cellular death and inflammatory responses. In the present study, we demonstrated how ex vivo photothermal (PT)-treated cells underwent immunogenic cell death. PT treatment caused significant expression of heat shock protein (HSP) 27, HSP70, and HSP90 in murine tumor cells. To evaluate the immunogenicity of heat-stressed cells, lysate from PT-treated tumor cells or water-based heated cells was pulsed to syngeneic bone-marrow-derived dendritic cells (DCs) to generate a DC-based vaccine. Administration with PT-treated tumor lysates-pulsed DC vaccine resulted in significant inhibition of tumor growth in BALB/c and C57BL/6 syngeneic tumor-bearing mice. The immunogenicity of PT-treated cancer cells was reduced in the presence of HSP inhibitors, J2, VER-155008 or 17-AAG. Our study elucidates how PT techniques have distinct mechanisms from water-based heating and might be a potentially robust and efficient solution to developing an anti-cancer vaccine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Microbiology and Immunology, College of Pharmacy, Inje University, 197 Injero, Gimhae, Gyeongnam 50834, Republic of Korea.
- Center for Nano Manufacturing and Department of Nanoscience and Engineering, Inje University, 197 Injero, Gimhae, Gyeongnam 50834, Republic of Korea.
- Laboratory of Microbiology and Immunology, College of Pharmacy, Inje University, 197 Injero, Gimhae, Gyeongnam 50834, Republic of Korea; Inje Institute of Pharmaceutical Science and Research, Inje University, Republic o…
Förderung
- Ministry of Science, ICT and Future Planning
- National Research Foundation of Korea
Zitieren
APA
Yu, S. H., Yoon, I., & Kim, Y. J. (2024). Ex vivo photothermal treatment-induced immunogenic cell death for anticancer vaccine development. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2023.111450
Vancouver
Yu SH, Yoon I, Kim YJ. Ex vivo photothermal treatment-induced immunogenic cell death for anticancer vaccine development. International Immunopharmacology. 2024. doi:10.1016/j.intimp.2023.111450
BibTeX
@article{Yu2024,
author = {Yu, Su Hyun and Yoon, Il and Kim, Yeon-Jeong},
title = {Ex vivo photothermal treatment-induced immunogenic cell death for anticancer vaccine development},
journal = {International Immunopharmacology},
year = {2024},
doi = {10.1016/j.intimp.2023.111450}
}
EUVIMED